Literature DB >> 6275934

Postexposure immunoprophylaxis against B virus (Herpesvirus simiae) infection.

E A Boulter, H T Zwartouw, B Thornton.   

Abstract

Local infiltration of antiserum into sites inoculated with B virus protected rabbits from an otherwise fatal encephalomyelitis. Treatment was effective when delayed for six hours but not after 24 hours. Homologous rabbit antisera were more effective than heterologous monkey antisera, and protection was unrelated to neutralisation titres. Protection apparently depended not on neutralisation of inoculated virus but on destruction of infected cells before they produced progeny virus. Normal human immunoglobulin able to neutralise B virus did not protect. Intravenously administered antibody was effective only if large doses were given. The findings suggest that persons bitten or scratched by monkeys latently infected with B virus may be treated successfully by immunoprophylaxis with specific antibody. Stocks of human or of more readily available simian antisera should be held in laboratories where such animals are used.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6275934      PMCID: PMC1507841          DOI: 10.1136/bmj.283.6305.1495

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  12 in total

1.  Hyperimmunized horse anti-B virus globulin: preparation and effectiveness.

Authors:  D A BUTHALA
Journal:  J Infect Dis       Date:  1962 Sep-Oct       Impact factor: 5.226

2.  Treatment of wounds from animals suspected of carrying neurotropic viruses.

Authors:  L Klenerman; C R Coid; F Y Aoki
Journal:  Br Med J       Date:  1975-09-27

3.  Recovery of herpes simiae (B virus) from both primary and latent infections in rhesus monkeys.

Authors:  A D Vizoso
Journal:  Br J Exp Pathol       Date:  1975-12

4.  Latent infection of monkeys with B virus and prophylactic studies in a rabbit model of this disease.

Authors:  E A Boulter; D P Grant
Journal:  J Antimicrob Chemother       Date:  1977-03       Impact factor: 5.790

5.  Herpes B virus encephalomyelitis presenting as ophthalmic zoster. A possible latent infection reactivated.

Authors:  J Fierer; P Bazely; A I Braude
Journal:  Ann Intern Med       Date:  1973-08       Impact factor: 25.391

6.  Correlation of B virus and herpes simplex virus antibodies in human sera.

Authors:  V J Cabasso; W A Chappell; J E Avampato; J L Bittle
Journal:  J Lab Clin Med       Date:  1967-07

7.  Latency of Herpes Simiae (B virus) in rabbits.

Authors:  A D Vizoso
Journal:  Br J Exp Pathol       Date:  1975-12

8.  Successful treatment of experimental B virus (Herpesvirus simiae) infection with acyclovir.

Authors:  E A Boulter; B Thornton; D J Bauer; A Bye
Journal:  Br Med J       Date:  1980-03-08

9.  Encephalomyelitis due to infection with Herpesvirus simiae (herpes B virus); a report of two fatal, laboratory-acquired cases.

Authors:  K HUMMELER; W L DAVIDSON; W HENLE; A C LABOCCETTA; H G RUCH
Journal:  N Engl J Med       Date:  1959-07-09       Impact factor: 91.245

10.  Isolation of B virus (herpes group) from the central nervous system of a rhesus monkey.

Authors:  J L MELNICK; D D BANKER
Journal:  J Exp Med       Date:  1954-08-01       Impact factor: 14.307

View more
  4 in total

1.  Papiine herpesvirus 2 as a predictive model for drug sensitivity of Macacine herpesvirus 1 (monkey B virus).

Authors:  Lauren A Brush; Darla H Black; Kimberly A Mccormack; Lara K Maxwell; George Wright; Jerry W Ritchey; Mark E Payton; Richard Eberle
Journal:  Comp Med       Date:  2014-10       Impact factor: 0.982

2.  Postexposure immunoprophylaxis against B virus infection.

Authors:  C C Baker; H P Lambert; M H Wansbrough-Jones
Journal:  Br Med J (Clin Res Ed)       Date:  1982-11-06

3.  Effective Prophylactic Therapy for Exposure to Monkey B Virus (Macacine alphaherpesvirus 1).

Authors:  Lara K Maxwell; Darla H Black; George E Wright; Melanie A Breshears; Richard Eberle
Journal:  Comp Med       Date:  2019-12-06       Impact factor: 1.565

Review 4.  Questioning the Extreme Neurovirulence of Monkey B Virus (Macacine alphaherpesvirus 1).

Authors:  R Eberle; L Jones-Engel
Journal:  Adv Virol       Date:  2018-02-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.